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Human Mesenchymal Stem Cells (hMSCs) are key raw material in Regenerative Medicine and are widely used 
for therapeutics, engineered tissues, and medical devices. Yet, achieving an economical bioprocess for hMSC 
production remains a significant challenge for industry. Bioprocess economic modeling highlights media as a 
major cost driver in cell manufacturing. Hence, the availability of efficient and robust xeno-free bioprocessing 
media will not only reduce manufacturing cost, but also decrease regulatory burden associated with bovine 
serum components found in traditional culture media. Here, we evaluated and compared hMSCs quality 
parameters in bovine serum-containing and xeno-free bioprocess media formulations and assessed quality 
parameters such as cell identity, potency and functionality. Cells in xeno-free media maintained critical hMSC 
functional properties including angiogenic cytokine (FGF, HGF, IL8, TIMP1, TIMP2, and VEGF) secretion, 
trilineage differentiation, and immunomodulatory potential. In addition, hMSCs cultured in xeno-free media 
expanded rapidly and achieved confluency within 4-5 days of culture without media exchange. The economics 
of hMSC expansion in this xeno-free media were modeled and compared to other competitive hMSC cell or 
media systems where it consistently outperformed traditional hMSC systems by more than 8 fold on the critical 
productivity metric of Million cells per Liter, making it ideal for industrial-scale manufacturing of hMSCs.  
 
 
 
